only with
IOL Chemicals And Pharmaceuticals Ltd.
IOL Chem & Pharma
IOL Chemicals And Pharmaceuticals Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap - With a market cap of ₹57.27 Cr.
| EX-Date | Purpose |
|---|---|
| 04 06 2021 | Audited Results |
| 13 08 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 04 02 2022 | Quarterly Results & Interim Dividend |
| 30 05 2022 | Quarterly Results |
| 09 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 07 02 2023 | Interim Dividend & Audited Results |
| 28 04 2023 | Audited Results & Quarterly Results |
| 09 08 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 06 02 2024 | Quarterly Results & Interim Dividend |
| 14 11 2024 | Quarterly Results |
| 27 12 2024 | Stock Split Inter-alia to consider and approve the alteration in the share capital of the Company by sub-division / split of existing equity shares having face value of Rs. 10/- each, fully paid up, as may be determined by the Board of Directors. |
| 12 02 2025 | Quarterly Results & Interim Dividend |
| 16 05 2025 | Quarterly Results & Audited Results |
| 11 11 2025 | Quarterly Results |
| 11 02 2026 | Quarterly Results & Interim Dividend |
| 20 05 2026 | Audited Results & Quarterly Results |
| 10 08 2026 | Quarterly Results |
News
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma reports Profit after tax of Rs 644.80 Mln, in the June 2026 quarter
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma reports Profit after tax of Rs 531.80 Mln, in the March 2026 quarter
IOL Chemicals & Pharmaceuticals informs about disclosure
IOL Chemicals & Pharmaceuticals informs about disclosure
IOL Chemicals & Pharmaceuticals informs about disclosure
IOL Chemicals soars on getting Certificate of Suitability from EDQM
The company has secured Certificate of Suitability for its API product ‘CLOPIDOGREL BESILATE’
IOL Chemicals and Pharmaceuticals gets Certificate of Suitability from EDQM
The company has secured Certificate of Suitability for its API product ‘CLOPIDOGREL BESILATE’
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma reports Profit after tax of Rs 205.80 Mln, in the December 2025 quarter
IOL Chemicals and Pharmaceuticals informs about update
IOL Chem & Pharma reports Profit after tax of Rs 300.00 Mln, in the September 2025 quarter
IOL Chemicals gets certificate of suitability from EDQM
The company has received certificate of suitability for its API product ‘Sitagliptin Phosphate Monohydrate’
IOL Chemicals incorporates wholly owned subsidiary in United Kingdom
The WOS is incorporated to carry on the business in the field of Pharmaceuticals/Chemicals
IOL Chemicals and Pharmaceuticals informs about updates
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma reports Profit after tax of Rs 339.60 Mln, in the June 2025 quarter
IOL Chem & Pharma - Quaterly Results
IOL Chemicals inches up on registering Acetic Anhydride with REACH
This certification allows the company to export the product across all the countries in the European Union
IOL Chemicals registers Acetic Anhydride with REACH
This certification allows the company to export the product across all the countries in the European Union
IOL Chemicals & Pharmaceuticals informs about outcome of board meeting
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma reports Profit after tax of Rs 316.20 Mln, in the March 2025 quarter
IOL Chem & Pharma - Quaterly Results
IOL Chemicals zooms on securing approval for Ibuprofen from CDE in China
This approval authorizes the company to export Ibuprofen to the Chinese markets
IOL Chemicals secures approval for Ibuprofen from CDE in China
This approval authorizes the company to export Ibuprofen to the Chinese markets
IOL Chemicals & Pharmaceuticals informs about trading window closure
IOL Chemicals commences new Unit 11 for Paracetamol production in Punjab
The company has enhanced the installed capacity of Unit 5 for manufacturing Clopidogrel Bisulphate from 180 MTPA to 240 MT
IOL Chemicals and Pharmaceuticals gets Certificate of Suitability from EDQM
This certification will enable the company to export Quetiapine Fumarate to European and other countries
IOL Chemicals and Pharmaceuticals reports 11% fall in Q3 consolidated net profit
Total consolidated income of the company decreased marginally at Rs 527.37 crore for Q3FY25
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma reports Profit after tax of Rs 205.50 Mln, in the December 2024 quarter
IOL Chemicals & Pharmaceuticals informs about newspaper publication
IOL Chemicals & Pharmaceuticals informs about disclosures
IOL Chemicals and Pharmaceuticals informs about issuance letter of confirmation
IOL Chem & Pharma reports Profit after tax of Rs 191.50 Mln, in the September 2024 quarter
IOL Chem & Pharma - Quaterly Results
IOL Chemicals and Pharmaceuticals informs about outcome of board meeting
IOL Chemicals & Pharmaceuticals informs about details of loss of certificate
IOL Chemicals zooms on completing ANVISA GMP audit of 10 manufacturing units without any observation
The inspection was conducted from March 11, 2024 to March 15, 2024
IOL Chemicals completes ANVISA GMP audit of 10 manufacturing units without any observation
The inspection was conducted from March 11, 2024 to March 15, 2024
IOL Chemicals gets approval for ‘Metformin Hydrochloride’ from CDE in China
Metformin Hydrochloride is an antidiabetic drug which is used to manage the high blood sugar levels in diabetes patients
IOL Chemicals gains on getting nod to wind up ‘M/s IOL Global’ in UK
The Board of Directors in its meeting held on February 06, 2024 has inter alia considered and approved the same
IOL Chemicals gets nod to wind up ‘M/s IOL Global’ in UK
The Board of Directors in its meeting held on February 06, 2024 has inter alia considered and approved the same
IOL Chemicals and Pharmaceuticals reports marginal fall in Q3 consolidated net profit
Total consolidated income of the company decreased by 0.26% at Rs 528.77 crore for Q3FY24
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma reports Profit after tax of Rs 232.30 Mln, in the December 2023 quarter
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
Iol Chemicals & Pharmaceuticals informs about analyst meet
IOL Chem & Pharma reports Profit after tax of Rs 377.90 Mln, in the September 2023 quarter
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chemicals and Pharmaceuticals informs about disclosure
IOL Chemicals and Pharmaceuticals informs about disclosure
IOL Chem & Pharma reports Profit after tax of Rs 462.10 Mln, in the June 2023 quarter
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chemicals & Pharmaceuticals informs about details of loss of certificate
Iol Chemicals & Pharmaceuticals informs about press release
IOL Chemicals commences Plant for Acetic Anhydride
The company sets up a state of the art plant that is more viable, technically, and financially, as compared to existing technology
IOL Chemicals & Pharmaceuticals informs about presentation
IOL Chemicals and Pharmaceuticals informs about investor conference call
IOL Chemicals and Pharmaceuticals informs about press release
IOL Chemicals surges on getting Certificate of Suitability to export Paracetamol in European market
The certification issued by the EDQM verifies the compliance of pharmaceutical substances and with this backing, IOL will now be able to export Paracetamol to the European continent
IOL Chemicals gets Certificate of Suitability to export Paracetamol in European market
The certification issued by the EDQM verifies the compliance of pharmaceutical substances and with this backing, IOL will now be able to export Paracetamol to the European continent
Iol Chemicals & Pharmaceuticals informs about press release
Iol Chemicals & Pharmaceuticals informs about loss of share certificate
IOL Chemicals and Pharmaceuticals reports 2- fold jump in Q4 consolidated net profit
Total consolidated income of the company marginally increased by 2.85% at Rs 595.94 crore for Q4FY23
IOL Chemicals & Pharmaceuticals informs about outcome of board meeting
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma reports Profit after tax of Rs 652.70 Mln, in the March 2023 quarter
IOL Chemicals & Pharmaceuticals informs about clarification on price movement
IOL Chemicals & Pharmaceuticals informs about press release
Iol Chemicals & Pharmaceuticals informs about analyst meet
IOL Chemicals and Pharmaceuticals reports 40% fall in Q3 net profit
Total income of the company decreased 6.01% at Rs 530.12 crore for Q3FY23
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chemicals and Pharmaceuticals informs about board meeting
IOL Chemicals and Pharmaceuticals incorporates wholly owned subsidiary in UK
The WOS is incorporated to carry on the business in the field of Pharmaceuticals/Chemicals
IOL Chemicals and Pharmaceuticals informs about analyst meet
IOL Chemicals and Pharmaceuticals zooms on receiving patent from Government of India
The patent is for invention entitled an improved safe process for the preparation of Sartan Drugs of formula I
IOL Chemicals and Pharmaceuticals receives patent from Government of India
The patent is for invention entitled an improved safe process for the preparation of Sartan Drugs of formula I
IOL Chemicals and Pharmaceuticals gains on getting nod to incorporate wholly owned subsidiary
The board of directors at its meeting held on November 14, 2022 has approved the same
IOL Chemicals and Pharmaceuticals gets nod to incorporate wholly owned subsidiary
The board of directors at its meeting held on November 14, 2022 has approved the same
IOL Chemicals and Pharmaceuticals reports 69% fall in Q2 consolidated net profit
Total consolidated income of the company decreased by 51.06% at Rs 546.48 crore for Q2FY23
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chemicals gets CEP to supply Pantoprazole Sodium Sesquihydrate API in Europe
With this CEP certification, the company will now be able to export it to entire Europe
IOL Chemicals and Pharmaceuticals informs about disclosure
IOL Chemicals and Pharmaceuticals informs about loss of share certificate
IOL Chemicals receives REACH certification for supply of ethyl acetate across European markets
The company exports ethyl acetate to more than 40 countries
IOL Chemicals and Pharmaceuticals surges on getting nod to invest $2.1 million in USpharma
The Board of Directors in its meeting held on September 22, 2022 has inter alia considered and approved the same
IOL Chemicals and Pharmaceuticals gets nod to invest $2.1 million in USpharma
The Board of Directors in its meeting held on September 22, 2022 has inter alia considered and approved the same
IOL Chemicals and Pharmaceuticals informs about transcript of conference call
IOL Chem & Pharma - Quaterly Results
IOL Chem & Pharma - Quaterly Results
IOL Chemicals and Pharmaceuticals inches up on incorporating wholly owned subsidiary
The wholly owned subsidiary is incorporated to carry on the business in the field of Chemicals
IOL Chemicals and Pharmaceuticals incorporates wholly owned subsidiary
The wholly owned subsidiary is incorporated to carry on the business in the field of Chemicals
IOL Chemicals and Pharmaceuticals moves up on incorporating wholly owned subsidiary
The incorporation is to carry on the business in the field of Pharmaceuticals/Chemicals
IOL Chemicals and Pharmaceuticals incorporates wholly owned subsidiary
The incorporation is to carry on the business in the field of Pharmaceuticals/Chemicals